CN104056282A - Mindin基因在肝脏缺血再灌注损伤中的应用 - Google Patents
Mindin基因在肝脏缺血再灌注损伤中的应用 Download PDFInfo
- Publication number
- CN104056282A CN104056282A CN201410260263.6A CN201410260263A CN104056282A CN 104056282 A CN104056282 A CN 104056282A CN 201410260263 A CN201410260263 A CN 201410260263A CN 104056282 A CN104056282 A CN 104056282A
- Authority
- CN
- China
- Prior art keywords
- mindin
- hepatic
- gene
- reperfusion injury
- hepatic ischemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410260263.6A CN104056282B (zh) | 2014-06-11 | 2014-06-11 | Mindin基因在肝脏缺血再灌注损伤中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410260263.6A CN104056282B (zh) | 2014-06-11 | 2014-06-11 | Mindin基因在肝脏缺血再灌注损伤中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104056282A true CN104056282A (zh) | 2014-09-24 |
CN104056282B CN104056282B (zh) | 2016-09-28 |
Family
ID=51544396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410260263.6A Active CN104056282B (zh) | 2014-06-11 | 2014-06-11 | Mindin基因在肝脏缺血再灌注损伤中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104056282B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105624162A (zh) * | 2016-03-19 | 2016-06-01 | 嘉兴市第一医院 | 针对哺乳动物R-Spondin2基因靶点的小干扰RNA、短发卡RNA及载体和应用 |
CN105695465A (zh) * | 2016-03-19 | 2016-06-22 | 嘉兴市第医院 | 针对哺乳动物R-Spondin1基因靶点的小干扰RNA、短发卡RNA及载体和应用 |
CN110124015A (zh) * | 2019-05-25 | 2019-08-16 | 广西医科大学第一附属医院 | 一种胸腺基质淋巴细胞生成素的应用 |
CN114375897A (zh) * | 2020-10-20 | 2022-04-22 | 李岩 | 一种肢体缺血再灌注后肝损伤动物模型的构建方法 |
-
2014
- 2014-06-11 CN CN201410260263.6A patent/CN104056282B/zh active Active
Non-Patent Citations (2)
Title |
---|
LANG WANG 等: "Mindin is a critical mediator of ischemic brain injury in an experimental stroke model", 《EXPERIMENTAL NEUROLOGY》, vol. 247, 27 January 2013 (2013-01-27), pages 506 - 516 * |
LI-HUA ZHU 等: "Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor a in mice", 《JOURNAL OF HEPATOLOGY》, vol. 60, 18 January 2014 (2014-01-18), pages 1046 - 1054 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105624162A (zh) * | 2016-03-19 | 2016-06-01 | 嘉兴市第一医院 | 针对哺乳动物R-Spondin2基因靶点的小干扰RNA、短发卡RNA及载体和应用 |
CN105695465A (zh) * | 2016-03-19 | 2016-06-22 | 嘉兴市第医院 | 针对哺乳动物R-Spondin1基因靶点的小干扰RNA、短发卡RNA及载体和应用 |
CN105695465B (zh) * | 2016-03-19 | 2017-05-03 | 嘉兴市第一医院 | 针对哺乳动物R‑Spondin1基因靶点的小干扰RNA、短发卡RNA及载体和应用 |
CN110124015A (zh) * | 2019-05-25 | 2019-08-16 | 广西医科大学第一附属医院 | 一种胸腺基质淋巴细胞生成素的应用 |
CN114375897A (zh) * | 2020-10-20 | 2022-04-22 | 李岩 | 一种肢体缺血再灌注后肝损伤动物模型的构建方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104056282B (zh) | 2016-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bussolati et al. | The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells | |
CN104056282A (zh) | Mindin基因在肝脏缺血再灌注损伤中的应用 | |
CN111840514B (zh) | Cilp2在制备改善心脏衰老和心肌肥厚的药物中的应用 | |
Borrás | The cellular and molecular biology of the iris, an overlooked tissue: the iris and pseudoexfoliation glaucoma | |
Gawande et al. | Cardiac changes in hospitalized patients of trauma | |
CN106620721A (zh) | 单核细胞趋化蛋白‑1诱导蛋白1(Mcpip1)在肝缺血再灌注损伤中的应用 | |
CN109613258A (zh) | 一种溃疡性结肠炎生物标记物及治疗靶点的应用 | |
Wu et al. | A microfibril-associated glycoprotein 4 (MFAP4) from Nile tilapia (Oreochromis niloticus) possesses agglutination and opsonization ability to bacterial pathogens | |
CN106421789A (zh) | Mincle及其抑制剂在肝缺血再灌注损伤中的应用 | |
CA3109199A1 (en) | Drug used for treating tissue necrosis or for improving cardiac function | |
CN106492230B (zh) | 白细胞免疫球蛋白样受体b4在治疗非酒精性脂肪肝和ⅱ型糖尿病中的功能和应用 | |
CN103784971B (zh) | Irf3基因在动脉粥样硬化中的功能及其抑制剂的应用 | |
CN103784976B (zh) | 干扰素调节因子9(irf9)及其抑制剂在肝脏缺血疾病中的应用 | |
CN103784970B (zh) | Tnf受体相关因子1(tarf1)及其抑制剂在肝脏缺血疾病中的应用 | |
Feliz-Norberto et al. | Neutrophil reverse migration from liver fuels neutrophilic inflammation to tissue injury in Nonalcoholic Steatohepatitis | |
CN104043108A (zh) | 锌指蛋白a20在治疗脂肪肝和ⅱ型糖尿病中的功能和应用 | |
CN102166346B (zh) | Lrrc10小分子及其在制备治疗心肌肥厚药物中的应用 | |
Pan et al. | Effect of Methyl-CpG binding domain protein 2 (MBD2) on AMD-like lesions in ApoE-deficient mice | |
CN103784970A (zh) | Tnf受体相关因子1(tarf1)及其抑制剂在肝脏缺血疾病中的应用 | |
CN104069483B (zh) | 肿瘤抑制因子cylindromatosis在治疗脂肪肝和Ⅱ型糖尿病中的功能和应用 | |
CN106390125A (zh) | 干扰素调节因子2结合蛋白2在治疗脂肪肝和ⅱ型糖尿病中的功能和应用 | |
CN106498057A (zh) | 三结构域蛋白8在治疗非酒精性脂肪肝和ⅱ型糖尿病中的功能和应用 | |
CN106421815B (zh) | 双特异性磷酸酶14(Dusp14)在肝缺血再灌注损伤中的应用 | |
CN104174011A (zh) | 离心力和剪切力应答蛋白1(recs1)在治疗心肌肥厚中的功能及应用 | |
CN106390124A (zh) | 炎症抑制因子Numbl在治疗脂肪肝和Ⅱ型糖尿病中的功能和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191120 Address after: 430040 No.1, floor 1, No.17, eleven village, Changqing Garden, Dongxihu District, Wuhan City, Hubei Province (18) Patentee after: Wuhan Dafeng Biotechnology Co., Ltd Address before: 430072 Hubei Province, Wuhan city Wuchang District of Wuhan University Luojiashan Patentee before: WuHan University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191218 Address after: 430014 3119, floor 3, building 9, Guanggu science and technology port, 18 huashiyuan North Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province Patentee after: Wuhan linyijia Gene Technology Co., Ltd Address before: 430040 No.1, floor 1, No.17, eleven village, Changqing Garden, Dongxihu District, Wuhan City, Hubei Province (18) Patentee before: Wuhan Dafeng Biotechnology Co., Ltd |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 430076 room 002, 16 / F, building D2, phase III, software new town, No. 8, Huacheng Avenue, Wuhan East Lake New Technology Development Zone, Wuhan, Hubei Province Patentee after: Wuhan Huikang Gene Technology Co.,Ltd. Address before: Room 3119, 3 / F, building 9, Guanggu science and technology harbor, 18 huashiyuan North Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province, 430014 Patentee before: Wuhan linyijia Gene Technology Co.,Ltd. |